Synovus downgraded at Raymond James on potential EPS downside risk

As previously reported, Raymond James downgraded Synovus (SNV) to Market Perform from Outperform with no price target The firm sees potential EPS downside risk given the company’s wide-ranging 2025 outlook and concern that shares could suffer from any re-emergence of industry credit fears, the analyst tells investors. The firm now views the risk-reward as balanced, but continue to view Synovus’ fundamental story positively given ongoing franchise investment and growth prospects in its “attractive Southeastern footprint,” the analyst added.